HCW Biologics Regains Nasdaq Compliance, 1-for-6 Reverse Split Effective Today
HCWB is trading near its 52-week low of $1.5 (31% below the low).
Summary
HCW Biologics has regained compliance with Nasdaq's minimum bid price rule, effective June 29, 2026. This follows shareholder approval on June 15th for a reverse stock split, which was necessary to address the company's stock trading below the $1 minimum. To ensure long-term compliance, a 1-for-6 reverse stock split will be effected today, June 30, 2026. Maintaining Nasdaq listing is crucial for this micro-cap company, preventing a potential delisting that would severely impact liquidity and investor confidence. The company will be monitored through June 17, 2027, for continued compliance.
At the time of this announcement, HCWB was trading at $1.03 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6.3M. The 52-week trading range was $1.50 to $44.10. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.